Svas Biosana SpA

Svas Biosana SpA FCF Margin

The Free Cash Flow Margin of Svas Biosana SpA (SVS.MI) as of Nov 4, 2026 is -4.02 %. In the previous year, Free Cash Flow Margin was -0.81 % — a change of 396.00% (lower).

FCF Margin

-4.02 %

YoY

396.00%

Last updated:

Free Cash Flow Margin of Svas Biosana SpA is 2025 -4.02 % . Free Cash Flow Margin of Svas Biosana SpA was 2024 -0.81 % . It decreases by 396.00% lower compared to the previous year.

The Svas Biosana SpA FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-0.01 EUR
Jan 1, 2019
3.31 EUR
Jan 1, 2020
13.74 EUR
Jan 1, 2021
-0.10 EUR
Jan 1, 2022
0.01 EUR
Jan 1, 2023
-1.26 EUR
Jan 1, 2024
-0.81 EUR
Jan 1, 2025
-4.02 EUR
The Svas Biosana SpA FCF Margin history
YEARFCF MarginYoY
-4.02 %+396.00%
-0.81 %-35.74%
-1.26 %-11,570.33%
0.01 %-110.67%
-0.10 %-100.75%
13.74 %+314.94%
3.31 %-32,798.02%
-0.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Svas Biosana SpA Stock analysis

What does Svas Biosana SpA do? Svas Biosana SpA distributes medical appliances through its four divisions: Farmex manufactures gauze and cotton products, Medical provides suction lines, infusion lines, and custom packs, Svas offers own brand products including specialities, galenic solutions, and disposables, and Harvest supplies electromedical equipment with after-sales technical services. The company is a subsidiary of Svas group and serves healthcare providers and medical facilities. The firm's products are sold to hospitals, clinics, and healthcare institutions requiring medical supplies and equipment. Svas Biosana SpA generates revenue from the sale of its medical appliance products across all four divisions. Farmex's gauze and cotton products are purchased by healthcare institutions for wound care and medical procedures. Medical division's suction and infusion lines are bought by hospitals for patient care and treatment. Svas division's own brand products, including specialities and disposables, are sold to medical facilities seeking branded solutions. Harvest division's electromedical equipment and technical services are contracted by healthcare providers needing advanced medical devices and support. The company's business model focuses on distributing medical appliances through its four specialized divisions, each targeting specific segments of the healthcare market. Farmex serves the basic medical supplies segment with gauze and cotton products. Medical targets acute care settings with suction and infusion lines. Svas division caters to facilities requiring branded medical products and solutions. Harvest division addresses the need for electromedical equipment and technical support services in healthcare environments. All divisions contribute to the company's revenue through direct sales to healthcare institutions and providers. Svas Biosana SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Svas Biosana SpA stock

Free Cash Flow Margin of Svas Biosana SpA is -4.02 % in 2025.

Free Cash Flow Margin of Svas Biosana SpA changed from -0.81 % to -4.02 %, representing a 396.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Svas Biosana SpA since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Svas Biosana SpA with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Svas Biosana SpA

All Key Metrics — Svas Biosana SpA